Biomarkers: Diabetes, Obesity & Heart

Molecular Biomarkers can be demarcated as “a characteristic that is accurately measured and gauged as an pointer of normal biological procedures, pathogenic procedures, or pharmacologic responses to a pharmaceutical intervention. Biomarkers play a vital part in leading clinical trials and treating patients. Advances in molecular diagnostics help medical professionals make knowledgeable, scientifically valid decisions. More well-organized discovery and usage of biomarkers in the growth of anti-diabetes drugs will depend on accelerating our understanding of the pathogenesis of diabetes and specifically its macrovascular complications.  Procedural improvements from other fields, especially cancer, are beginning to show the way towards better models of diabetes pathogenesis and molecular biomarker discovery.

    Related Conference of Biomarkers: Diabetes, Obesity & Heart

    December 07-08, 2020

    13th World Congress on Endocrinology and Metabolic Disorders

    Auckland, Newzealand
    March 17-18, 2021

    30th European Diabetes Congress

    Barcelona, Spain
    March 22-23, 2021

    Global summit on Diabetes and Endocrinology

    London, UK
    April 13-14, 2021

    World congress on Endocrinology and Metabolic syndrome

    Auckland, Newzealand
    May 10-11, 2021

    30th World Diabetes & Heart Congress

    Singapore, Singapore
    September 02-03, 2021

    5th Annual Congress on Diabetes, Obesity and Its Complications

    Vienna, Australia
    October 18-19, 2021

    2nd Annual Summit on Diabetes and Endocrinology

    Paris, France

    Biomarkers: Diabetes, Obesity & Heart Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in